UniProt ID | YKT6_HUMAN | |
---|---|---|
UniProt AC | O15498 | |
Protein Name | Synaptobrevin homolog YKT6 | |
Gene Name | YKT6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 198 | |
Subcellular Localization |
Cytoplasm, cytosol. Cytoplasmic vesicle membrane Lipid-anchor Cytoplasmic side. Golgi apparatus membrane Lipid-anchor Cytoplasmic side. Probably cycles through vesicles between Golgi and endosomes. |
|
Protein Description | Vesicular soluble NSF attachment protein receptor (v-SNARE) mediating vesicle docking and fusion to a specific acceptor cellular compartment. Functions in endoplasmic reticulum to Golgi transport; as part of a SNARE complex composed of GOSR1, GOSR2 and STX5. Functions in early/recycling endosome to TGN transport; as part of a SNARE complex composed of BET1L, GOSR1 and STX5. Has a S-palmitoyl transferase activity.. | |
Protein Sequence | MKLYSLSVLYKGEAKVVLLKAAYDVSSFSFFQRSSVQEFMTFTSQLIVERSSKGTRASVKEQDYLCHVYVRNDSLAGVVIADNEYPSRVAFTLLEKVLDEFSKQVDRIDWPVGSPATIHYPALDGHLSRYQNPREADPMTKVQAELDETKIILHNTMESLLERGEKLDDLVSKSEVLGTQSKAFYKTARKQNSCCAIM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MKLYSLSVLYK ----CCEEEEEEEEC | 11.31 | 21406692 | |
5 | Phosphorylation | ---MKLYSLSVLYKG ---CCEEEEEEEECC | 25.30 | 21406692 | |
15 | Acetylation | VLYKGEAKVVLLKAA EEECCCEEEEEEEEE | 28.68 | - | |
15 | Acetylation | VLYKGEAKVVLLKAA EEECCCEEEEEEEEE | 28.68 | 23236377 | |
51 | Phosphorylation | SQLIVERSSKGTRAS HHHHHHHCCCCCCCC | 23.93 | - | |
58 | Phosphorylation | SSKGTRASVKEQDYL CCCCCCCCHHHCCEE | 30.36 | 24719451 | |
64 | Phosphorylation | ASVKEQDYLCHVYVR CCHHHCCEEEEEEEC | 15.78 | 24719451 | |
71 | Dimethylation | YLCHVYVRNDSLAGV EEEEEEECCCCEEEE | 24.45 | - | |
71 | Methylation | YLCHVYVRNDSLAGV EEEEEEECCCCEEEE | 24.45 | 115390027 | |
88 | Dimethylation | ADNEYPSRVAFTLLE ECCCCCHHHHHHHHH | 21.19 | - | |
88 | Methylation | ADNEYPSRVAFTLLE ECCCCCHHHHHHHHH | 21.19 | 115390033 | |
96 | Ubiquitination | VAFTLLEKVLDEFSK HHHHHHHHHHHHHHH | 48.33 | - | |
103 | Ubiquitination | KVLDEFSKQVDRIDW HHHHHHHHCCCCCCC | 60.71 | 21890473 | |
103 | Acetylation | KVLDEFSKQVDRIDW HHHHHHHHCCCCCCC | 60.71 | - | |
103 | Ubiquitination | KVLDEFSKQVDRIDW HHHHHHHHCCCCCCC | 60.71 | 21890473 | |
103 | Acetylation | KVLDEFSKQVDRIDW HHHHHHHHCCCCCCC | 60.71 | 23236377 | |
103 | Methylation | KVLDEFSKQVDRIDW HHHHHHHHCCCCCCC | 60.71 | 42377385 | |
107 | Methylation | EFSKQVDRIDWPVGS HHHHCCCCCCCCCCC | 29.88 | 115920221 | |
114 | Phosphorylation | RIDWPVGSPATIHYP CCCCCCCCCCEEECC | 16.17 | 25159151 | |
117 | Phosphorylation | WPVGSPATIHYPALD CCCCCCCEEECCCCC | 16.21 | 22199227 | |
120 | Phosphorylation | GSPATIHYPALDGHL CCCCEEECCCCCCCH | 6.07 | 27080861 | |
128 | Phosphorylation | PALDGHLSRYQNPRE CCCCCCHHCCCCHHH | 24.22 | 27080861 | |
141 | Ubiquitination | READPMTKVQAELDE HHCCCCCHHHHHHCC | 26.54 | - | |
141 | Ubiquitination | READPMTKVQAELDE HHCCCCCHHHHHHCC | 26.54 | 21890473 | |
150 | Ubiquitination | QAELDETKIILHNTM HHHHCCCEEHHHHHH | 26.21 | 21890473 | |
156 | Phosphorylation | TKIILHNTMESLLER CEEHHHHHHHHHHHH | 16.15 | 23186163 | |
159 | Phosphorylation | ILHNTMESLLERGEK HHHHHHHHHHHHCCC | 27.68 | 27050516 | |
166 | Acetylation | SLLERGEKLDDLVSK HHHHHCCCHHHHHHH | 61.10 | 23236377 | |
166 | Ubiquitination | SLLERGEKLDDLVSK HHHHHCCCHHHHHHH | 61.10 | - | |
172 | Phosphorylation | EKLDDLVSKSEVLGT CCHHHHHHHHHHHCH | 37.45 | 25850435 | |
173 | Ubiquitination | KLDDLVSKSEVLGTQ CHHHHHHHHHHHCHH | 43.06 | 21890473 | |
174 | Phosphorylation | LDDLVSKSEVLGTQS HHHHHHHHHHHCHHH | 25.98 | 23401153 | |
179 | Phosphorylation | SKSEVLGTQSKAFYK HHHHHHCHHHHHHHH | 26.05 | 26699800 | |
181 | Phosphorylation | SEVLGTQSKAFYKTA HHHHCHHHHHHHHHH | 26.28 | 26699800 | |
182 | Ubiquitination | EVLGTQSKAFYKTAR HHHCHHHHHHHHHHH | 32.47 | 21890473 | |
182 | Acetylation | EVLGTQSKAFYKTAR HHHCHHHHHHHHHHH | 32.47 | 27452117 | |
186 | Ubiquitination | TQSKAFYKTARKQNS HHHHHHHHHHHHHCC | 29.29 | - | |
186 | Acetylation | TQSKAFYKTARKQNS HHHHHHHHHHHHHCC | 29.29 | 27452117 | |
194 | S-palmitoylation | TARKQNSCCAIM--- HHHHHCCCEECC--- | 2.08 | 15479160 | |
195 | Methylation | ARKQNSCCAIM---- HHHHCCCEECC---- | 2.63 | - | |
195 | Farnesylation | ARKQNSCCAIM---- HHHHCCCEECC---- | 2.63 | 15044687 | |
195 | S-palmitoylation | ARKQNSCCAIM---- HHHHCCCEECC---- | 2.63 | 15479160 | |
195 | Farnesylation | ARKQNSCCAIM---- HHHHCCCEECC---- | 2.63 | 15044687 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of YKT6_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of YKT6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of YKT6_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CNN3_HUMAN | CNN3 | physical | 26344197 | |
CRIP1_HUMAN | CRIP1 | physical | 26344197 | |
QOR_HUMAN | CRYZ | physical | 26344197 | |
ACBP_HUMAN | DBI | physical | 26344197 | |
ETFA_HUMAN | ETFA | physical | 26344197 | |
FKB1A_HUMAN | FKBP1A | physical | 26344197 | |
AATC_HUMAN | GOT1 | physical | 26344197 | |
MDHM_HUMAN | MDH2 | physical | 26344197 | |
MEMO1_HUMAN | MEMO1 | physical | 26344197 | |
MIF_HUMAN | MIF | physical | 26344197 | |
PEBP1_HUMAN | PEBP1 | physical | 26344197 | |
RIFK_HUMAN | RFK | physical | 26344197 | |
TAGL_HUMAN | TAGLN | physical | 26344197 | |
TAGL2_HUMAN | TAGLN2 | physical | 26344197 | |
TAGL3_HUMAN | TAGLN3 | physical | 26344197 | |
TKT_HUMAN | TKT | physical | 26344197 | |
UB2V1_HUMAN | UBE2V1 | physical | 26344197 | |
UFC1_HUMAN | UFC1 | physical | 26344197 | |
PTAR1_HUMAN | PTAR1 | physical | 28514442 | |
AASD1_HUMAN | AARSD1 | physical | 28514442 | |
C1QRF_HUMAN | C1QL1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Palmitoylation | |
Reference | PubMed |
"Localization and activity of the SNARE Ykt6 determined by itsregulatory domain and palmitoylation."; Fukasawa M., Varlamov O., Eng W.S., Soellner T.H., Rothman J.E.; Proc. Natl. Acad. Sci. U.S.A. 101:4815-4820(2004). Cited for: SUBCELLULAR LOCATION, MUTAGENESIS OF PHE-42; CYS-194 AND CYS-195,ISOPRENYLATION AT CYS-195, AND PALMITOYLATION. | |
"The human SNARE protein Ykt6 mediates its own palmitoylation at C-terminal cysteine residues."; Veit M.; Biochem. J. 384:233-237(2004). Cited for: CATALYTIC ACTIVITY, MUTAGENESIS OF PHE-42; CYS-194 AND CYS-195, ANDPALMITOYLATION AT CYS-194. | |
Prenylation | |
Reference | PubMed |
"Localization and activity of the SNARE Ykt6 determined by itsregulatory domain and palmitoylation."; Fukasawa M., Varlamov O., Eng W.S., Soellner T.H., Rothman J.E.; Proc. Natl. Acad. Sci. U.S.A. 101:4815-4820(2004). Cited for: SUBCELLULAR LOCATION, MUTAGENESIS OF PHE-42; CYS-194 AND CYS-195,ISOPRENYLATION AT CYS-195, AND PALMITOYLATION. |